Objective: To assess the performance of the Pediatric Index of Mortality 3 score in a population of children admitted to PICUs in Argentina. Design: Prospective, national, multicenter study. Setting: Forty-nine PICUs located in Argentina belonging to public and private institutions. Patients: All children between 1 month and 16 years old admitted to the participating PICUs between May 15, 2016, and February 15, 2017. Interventions: None. Measurement and Main Results: A total of 6,602 patients were enrolled in the study. The observed mortality was 8% (531/6,602), whereas mortality predicted by Pediatric Index of Mortality 3 was 6.16% (407 deaths). The standardized mortality rate was 1.3 (95% CI, 1.20–1.42). The area under the receiver operating characteristic curve was 0.83 (95% CI, 0.82–0.85). The Hosmer-Lemeshow test showed that the difference between the mortality observed and the mortality predicted by Pediatric Index of Mortality 3 was statistically significant (χ2, 135.63; p
from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2DTUIn4
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose This study examined the effect of different knee flexion angles with a constant hip and knee torque on the muscle force...
-
Visual impairment in kurdistan and trend of epidemiologic eye studies in Iran Per Kallestrup Journal of Ophthalmic and Vision Research 2019 ...
-
Abstract Haemonchus contortus is a highly pathogenic gastrointestinal nematode of small ruminant animals. In modern intensive farming, li...
-
Users of the free 911 CDMX app can now get sound and vibration alerts for any quake strong enough to threaten damage in the city from EMS ...
-
Abstract Information on the viability of Toxoplasma gondii oocysts is crucial to establish the public health significance of this environ...
-
Objectives: To investigate the association between the concentration of the causative anions responsible for the main types of metabolic aci...
-
Academic Emergency Medicine, Volume 0, Issue ja , -Not available-. from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2x...
-
Abstract Background and Objectives Suvorexant is an orexin receptor antagonist indicated for the treatment of insomnia, characterized by...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου